DP71 and SERCA2 alteration in human neurons of a Duchenne muscular dystrophy patient
- 234 Downloads
Cognitive deficit has been identified in one third of patients affected by Duchenne Muscular Dystrophy, primarily attributed to loss of the short Dp71 dystrophin, the major brain dystrophin isoform. In this study, we investigated for the first time the Dp71 and Dp71-associated proteins cellular localization and expression in human neurons obtained by differentiation from induced pluripotent stem cell line of a patient affected by cognitive impairment. We found structural and molecular alterations in both pluripotent stem cell and derived neurons, reduced Dp71 expression, and a Ca2+ cytoplasmic overload in neurons coupled with increased expression of the SERCA2 pump in the dystrophic neurons. These results suggest that the reduction of Dp71 protein in the Duchenne muscular dystrophy neurons leads to alterations in SERCA2 and to elevated cytosolic Ca2+ concentration with consequent potential disruption of the dystrophin proteins and Dp71-associated proteins.
KeywordsDuchenne muscular dystrophy Dp71 dystrophin Pluripotent stem cell SERCA2 hiPSCs Neurons
Water channel aquaporin-4
Human-induced pluripotent stem cells
Peripheral blood mononuclear cells
Ca/ATPasic pump 2 -isoform of brain
Neuron-specific class III β-tubulin
Mutations in the dmd gene are responsible for the Duchenne muscular dystrophy (DMD) disease , in which muscular degeneration is also associated with cognitive defects likely due to loss of the smallest product of the dmd gene, the Dp71 dystrophin isoform . Dp71 is the most abundant dystrophin gene product in the adult brain [3, 4], and DMD patients with Dp71 partial ablation display severe mental retard with a reduction of the mean intelligence quotient (IQ) by about 1 standard deviation . In the CNS, Dp71 is detected in neurons , but little is known about its function for no availability of DMD patient’s brain tissues. Differentiation of hiPSCs into neural cells provides a recent technology to generate living neurons genetically identical to the patients’ ones. In this study, we have used the hiPSCs obtained from a DMD patient affected by serious cognitive impairment, to generate the correspondent neuronal lineage with the aim to establish a cell model to disclose the role of the Dp71 in the neuronal alterations associated with DMD. We have performed ultrastructural characterization and expression analysis for Dp71 and DAPs including AQP4 and βDG in both DMD hiPSCs and neurons. Moreover, to better understand the mechanism leading to alterations of neuronal cells in DMD brain, we have investigated the relationship between Dp71 and SERCA2 in DMD neurons. We evaluated the permeability of the endoplasmic reticulum (ER) blocking the SERCA2 pump by the specific inhibitor CPA. The results showed structural and molecular alterations in hiPSCs and neurons cells, a reduction of Dp71, and DAPs transcription and transduction. Interestingly, intracellular Ca2+ homeostasis was impaired in dystrophic neurons suggesting that, as in the dystrophic muscle [7, 8], an abnormal increase of intracellular Ca2+ could be involved as early pathogenic event of mental retard in DMD.
Materials and methods
Detailed methods are included in Additional file 1.
A 22-year-old patient shows a severe motor impairment; his total intelligence quotient (IQ), assessed with Wechsler Intelligence Scale for Children–Fourth Edition (WISC-IV), is 68, confirming the mild intellectual disability previously diagnosed (Additional file 1).
Generation of DMD hiPSCs
We have collected samples of PBMCs from a DMD patient and healthy donor. The PBMCs were reprogrammed to obtain the hiPSCs line as described in Additional file 1.
hiPSCs were maintained in supplemented mTeSR medium (Stem Cell Technologies) under standard conditions. hiPSCs were differentiated to glutamatergic sensory neurons using a previously described protocol [9, 10] (Additional file 1).
The hiPSCs and neurons cells were fixed and embedded in Epon 812. Semithin and ultrathin sections were performed as described in Additional file 1.
Dual immunofluorescence confocal laser scanning microscopy and morphometric analysis
hiPSCs and neuronal cells were fixed and then exposed to primary and corresponding secondary antibodies (Additional file 1: Table S1). The cells were examined under a Leica TCS SP2 (Leica, Wetzlar, Germany) confocal laser scanning microscope (Additional file 1).
The expression of mRNA for Dp71, AQP4, Dys, DG, and SERCA2 was evaluated by real-time PCR (Chromo4 Real-Time PCR Detection System - Bio-Rad Laboratories), and samples were normalized to cyclophylin-A as housekeeping gene (Additional file 1).
The protein content of Dp71, AQP4, Dys, DG, and SERCA2 was evaluated by immunoblotting analysis (Additional file 1).
Both control and patient’s iPSC-derived glutamatergic neurons, plated on 35-mm culture dishes, were recorded at room temperature. Whole cell experiments were performed with a Multiclamp 700B amplifier (Axon CNS-Molecular Devices, Sunnyvale, CA, USA) connected to an Axon Digidata 1500 (Axon Instrument-Molecular Devices, Sunnyvale, CA, USA). Currents were sampled at 10 kHz and low pass filtered at 5 kHz (Additional file 1).
Intracellular Ca2+ measurements
Cells were seeded on matrigel-coated glass coverslips (Ø 35 mm). Cells were loaded with 2–4 μM Fluo-4 (Thermo Fisher Scientific, Waltham, MA, USA) 25 min at 37 °C in DMEM. Coverslips with dye-loaded cells were mounted in a perfusion chamber (FCS2 Closed Chamber System, BIOPTECHS, Butler, USA), and measurements were performed using an inverted microscope (Nikon Eclipse TE2000-S microscope) equipped for single-cell fluorescence measurements and imaging analysis (Additional file 1).
Data are reported as means ± SEM. Student’s t test was used for two-group comparisons, and Bonferroni post-test was used to compare all treatment groups following one-way ANOVA. The Graph Pad Prim 5.0 statistical package (GraphPad Software, San Diego, CA, USA) was used for the analysis, and P < 0.05 values were considered statistically significant.
Ultrastructural and morphological alterations of DMD-hiPSCs
The dual confocal immunofluorescence reaction on DMD-hiPSCs for Dp71 and AQP4, Dp427 dystrophin (Dys) and βDG (Fig. 1d–q) showed the reduction of the proteins (Fig. 1g–i, o–q) while a strong fluorescence signal was present in the control (Fig. 1d–f, l–n). The distribution pattern of the Dp71 and AQP4 proteins changed in the patient’s hiPSCs (Fig. 1g–i) compared to the control (Fig. 1d–f).
The Dp71 protein was membrane disarranged and scattered in the cytoplasm (Fig. 1h), and separate Dp71 and AQP4 fluorescence signal was detected in DMD (Fig. 1g). Otherwise, Dp71 and AQP4 strongly colocalized on the membrane and cytoplasm of control (Fig. 1d). Furthermore, DMD-hiPSCs displayed a strong molecular rearrangement of Dys and βDG proteins with a dystrophin pointed fluorescence signals in cytoplasm (Fig. 1o, p) and reduced βDG green fluorescence, while a strong and polarized fluorescence in control ones was observed (Fig. 1l–n). Moreover, Dys and βDG colocalized in a short membrane tract only in the control hiPSCs (Fig. 1l). Morphometric analysis shows a meaningful reduction of Dp71, AQP4, Dys, and βDG fluorescence intensity in DMD-hiPSCs compared to controls (Fig. 1r). Real-time PCR experiments revealed a significant reduction in mRNA amount of Dp71, AQP4, Dys, and an increment of the messenger for DG in DMD-hiPSCs compared to control (Additional file 1: Figure S1). In parallel, immunoblotting experiments show a significant reduction of the Dp71, AQP4, Dys, and βDG protein content (Additional file 1: Figure S4).
Ultrastructural and morphological alterations of DMD neurons
In parallel, immunoblotting experiments show a significant reduction of the Dp71, AQP4, Dys, and βDG protein content (Additional file 1: Figure S4).
Alteration in SERCA2 and Dp71 expression and abnormal Ca2+ homeostasis in DMD-hiPSC-derived neurons
This increased expression of the SERCA pump in DMD neurons could likely shift the dynamic equilibrium between ER Ca2+ accumulation and Ca2+ passive leak toward a higher level of intraluminal Ca2+. Therefore, we evaluated SERCA2 activity as the passive Ca2+ permeability of the ER when the Ca2+-ATPase is blocked by CPA. This is a well-known experimental procedure that will increase cytosolic Ca2+ level as index of ER Ca2+ levels [11, 12]. In Fig. 4s, t, two representative experiments of ER Ca2+-depletion kinetics in Fluo-4 loaded control and DMD-neurons are shown. The cells were treated with the SERCA blocker (20 μM CPA) while perfused with Ca2+-free medium. Of note, CPA-induced ER Ca2+ release was significantly reduced in DMD neurons (Fig. 4t) when compared with control cells (Additional file 1: Figure S4). This evidence does not correlate with the increased expression level of the SERCA pump in DMD neurons and could indicate the fact that in the ER of DMD neurons, the intraluminal Ca2+ levels are lower than in the ER of control neurons as previously reported for muscle tissue .
The investigation of DMD neuropathogenesis in human is hampered by the absence of a satisfactory human model. In the present study, we have used the hiPSC technology to generate three glutamatergic sensory neuronal lineages of DMD patient, and we have obtained a cell model able to identify morphostructural and functional alterations in patient’s hiPSCs and neurons cells. The results demonstrated that Dp71 and DAPs alterations were already present in dystrophic stem cells as in neurons and even if some genes were overexpressed, such as βDG in hiPSCs and βDG and Dys in neurons, Dp71 and DAPs proteins were reduced and disarranged in DMD hiPSCs and neurons. We hypothesize that the reduction in Dp71 and DAPs proteins content could be related to activation of ubiquitin-proteasome complex as demonstrated in our previous work on mdx mice . Moreover, the DMD hiPSCs and neurons showed ultrastructural modification similar to that observed in mdx mesenchymal stem cells . DMD is characterized by intracellular Ca2+ ([Ca2+]i) dyshomeostasis in skeletal and cardiac muscles [16, 17, 18, 19]. The association between the lack of dystrophin and intracellular Ca2+ dyshomeostasis has been validated also in cerebellar granule neurons isolated from mdx mice . Moreover, the presence of a chronic overload of Ca2+ with consequent cytotoxic effect on glutamatergic neurons could be correlated to degenerative neurological diseases. The current study is the first to show that Ca2+ dyshomeostasis occurs also in DMD sensorial neurons, as occurs in altered muscle. The elevation in [Ca2+]i appears to be due to an increase of Ca2+ release from intracellular stores such as sarco/endoplasmic reticulum (SR/ER) . The same cellular dysfunctions were associated with a spatial learning deficit in mdx mice . It is well established that disruption of intracellular Ca2+ homeostasis in neurons causes learning and memory dysfunctions, metabolic derangements, and cell death as it has been shown in several chronic diseases . Loss and/or reduction of Dp71 and DAPs are thought to contribute to severity of mental retard . Interestingly, we found that Dp71 co-localized with SERCA2, the main brain protein responsible for the removal of intracellular Ca2+, suggesting that functional alteration identified in DMD neurons could be related to Dp71 deficiency in DMD patient with mental retard. Furthermore, the overexpression of SERCA2 in DMD neurons suggests a neuronal mechanism to restore Ca2+ level in cytosol. SERCA pump is dysfunctional in severely affected muscles of mdx mice , but nothing is known about its functionality in the brain.
In conclusion, the Dp71 partial ablation and disarrangement correlate with abnormal Ca2+ homeostasis in human neurons. This altered molecular pathway may potentially contribute to altered brain function and cognitive deficits in DMD patients. Further studies are needed to clarify whether SERCA2 overexpression or its functional activity are involved in the impairment of ER-Ca2+ handling that we reported in DMD neurons. Identification of this ion channel and improved understanding of its regulation appear essential to better understand the disease for a possible new therapeutic approach.
The authors are grateful to Michelina de Giorgis for technical support.
Availability of data and materials
All data generated or analyzed during this study are included in this published article (and its Additional file 1).
SR and LV designed and performed the research, conducted the experiments, analyzed the data, and wrote the paper. TA, CR, RT, and ME conducted the molecular and morphologic experiments and analyzed the data. AG and RD conducted the electrophysiological experiments and analyzed the data. PC and JR conducted the cellular experiments. FO and LM were involved in the recruitment of the patient. NR and SD conducted the genetic experiments. DR and MT developed the concept and designed the research. BN directed, designed, and supervised the research and wrote the paper. All authors read and approved the final manuscript.
Ethics approval and consent to participate
The study was approved by the local Ethics Committee at the University of Bari Medical School, and the patient gave its informed consent in accordance with the declaration of Helsinki.
Consent for publication
The authors declare that they have no competing interests.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
- 22.Lopez JR, Kolster J, Uryash A, Estève E, Altamirano F, Adams JA. Dysregulation of Intracellular Ca2+ in Dystrophic Cortical and Hippocampal Neurons. Mol Neurobiol. 2018;55(1):603-18.Google Scholar
Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.